美国近距离放疗学会(ABS)局部晚期宫颈癌混合腔内-组织间插植近距离放疗共识指南
美国近距离放疗学会(ABS)组织妇科近距离放疗专家(医师和物理师)通过问卷调查和多次线上会议,总结在宫颈癌腔内插植中补充组织间插针的当前实践与要点,文件经全体专家组和ABS董事会审阅批准。共识讨论了混合近距离放疗在宫颈癌中应用日益增多,补充插针时需考虑急诊资源、计划设计、施源器选择以及术前、术中、术后影像,并讨论了常可从混合方法获益的困难病例的处理方式。结论认为混合近距离放疗提供剂量学优势,但增加操作复杂性;了解必要资源并明确各项考虑有助于减轻部分挑战、提高操作成功率。
要点
- 混合近距离放疗(腔内插植加补充组织间插针)在宫颈癌近距离放疗中应用日益增多,可提供剂量学优势。
- 补充组织间插针增加操作复杂性,需提前考虑急诊资源、计划设计、施源器选择及围术期影像。
- 共识针对常可从混合方法获益的困难病例讨论了处理方式。
- 了解必要资源并明确各项考虑有助于减轻挑战、提高操作成功率。
适用人群与场景
- 接受近距离放疗的宫颈癌患者,尤其是局部晚期宫颈癌。
- 常可从混合腔内-组织间插植方法获益的困难病例。
处置流程与药物剂量
- 补充组织间插针时需考虑急诊资源、计划设计、施源器选择以及术前、术中、术后影像。
- 混合近距离放疗操作复杂性增加,需了解必要资源并明确各项考虑以减轻挑战、提高操作成功率。
研究设计与关键结果
- ABS专家组(包括医师和物理师)通过问卷调查和多次线上会议总结当前实践与 approaches,文件经全体专家组和ABS董事会审阅批准。
- 混合近距离放疗在宫颈癌近距离放疗中应用日益增多,补充组织间插针涉及急诊资源、计划设计、施源器选择及围术期影像等关键考虑。
- 共识讨论了常可从混合方法获益的困难病例的处理方式。
- 结论认为混合近距离放疗提供剂量学优势但增加操作复杂性;了解必要资源和明确考虑可减轻挑战、提高操作成功率。
证据类型、等级与局限
- 证据类型:专家共识(美国近距离放疗学会发布)。
- 制定方法:专家组问卷调查和多次线上会议讨论,文件经全体专家组和ABS董事会审阅批准。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为混合近距离放疗对宫颈癌有剂量学优势但增加操作复杂性;了解必要资源和明确各项考虑可帮助减轻挑战、提高操作成功率。
指南或共识出处
- 美国近距离放疗学会(ABS)混合腔内-组织间插植近距离放疗共识指南(The American Brachytherapy Society consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: The purpose of this consensus statement from the American Brachytherapy Society (ABS) is to summarize important considerations for adding interstitial needles to intracavitary implants for cervix cancer brachytherapy.
METHODS: A panel of experts in Gynecologic Brachytherapy, including both physicians and physicists completed surveys and met virtually on multiple occasions to discuss and define current practices and approaches in order to summarize these for the ABS community. This document was drafted, reviewed and approved by the full panel and the ABS Board of Directors.
RESULTS: Hybrid brachytherapy is increasingly being utilized in cervix brachytherapy. In incorporating supplementary interstitial needles there are numerous key considerations including resources for an emergency, planning considerations, applicator selection, and pre-, intra- and postprocedural imaging. Additionally, approaches to challenging cases that would often benefit from a hybrid approach are discussed.
CONCLUSIONS: While hybrid brachytherapy offers dosimetric advantages for cervix brachytherapy, it increases procedure complexity. Being aware of the necessary resources and defining considerations can help mitigate some of the challenges and improve procedural success.
参考来源
- Chino J, Erickson B, Gaffney D, et al. The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer. Brachytherapy. 2025. PMID: 40447530. doi:10.1016/j.brachy.2025.05.001
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。